It will be important to better understand TYK2 to ensure that it is a safe therapeutic target; for example, we know that Tyk2 knockout mice exhibit a mild immunodeficiency61 and that humans carrying two loss-of-function alleles and thus completely lacking this enzyme develop immunodeficiency 35 (ref. 62). This evidence concerns the gene TYK2 and immunodeficiency disease.